Proper handling of continuous variables is crucial in healthcare research, for example, within regression modelling for descriptive, explanatory, or predictive purposes. However, inadequate methods ...

- Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 - - These findings support the ...

Stoke Therapeutics and Biogen Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS ...

– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – ...

Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society ...

The meeting included a discussion of thimerosal, a mercury-based preservative and longtime target of the anti-vaccine world. It was removed from nearly all U.S. vaccines in 2001.

The KOL presentation will review Arcturus’ interim clinical data from ARCT-810 Phase 2 trials evaluating the safety and pharmacodynamics of multiple doses of ARCT-810 in adolescent and adult ...

Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a ...

Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of ...

Learn how GraphRAG transforms unstructured text into structured data, revolutionizing AI retrieval with deeper insights and connections.

The steady march to the right across a vast number of counties reveals the extent of the nation's transformation in the Trump era, and the seriousness of the Democrats' problems.